Basic information Safety Supplier Related

2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole

Basic information Safety Supplier Related

2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole Basic information

Product Name:
2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole
Synonyms:
  • 1,7'-diMethyl-2'-propyl-1H,3'H-
  • TelMisartan IMpurity A(2-n-propyl-4-Methyl-6-(1-MethylbenziMidazole-2-yl)benziMidazole)
  • TelMisartan IMpurity A
  • TelMisartan Related CoMpound A
  • 4-Methyl-2-propyl-6-benziMidazolecarboxylic Acid, 97+%
  • 2-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazole
  • Imp. A:2-n-Propyl-4-methyl-6-(1'-methylbenzimidazole-2-yl)benzimidazole
  • 1,7'-Dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazole
CAS:
152628-02-9
MF:
C19H20N4
MW:
304.39
EINECS:
604-866-6
Product Categories:
  • Imidazoles
  • Chemical intermediate for Telmisartan
  • (intermediate of telmisartan)
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • pharmaceutical intermediates
  • INTERMEDIATESOF
  • Imidazol&Benzimidazole
Mol File:
152628-02-9.mol
More
Less

2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole Chemical Properties

Melting point:
130-135 °C(Solv: tetrahydrofuran (109-99-9))
Boiling point:
584.8±52.0 °C(Predicted)
Density 
1.23±0.1 g/cm3(Predicted)
vapor pressure 
0-0Pa at 20-25℃
storage temp. 
Sealed in dry,Room Temperature
solubility 
soluble in Methanol
form 
Powder
pka
11.86±0.30(Predicted)
color 
White to Light yellow to Light orange
InChI
InChI=1S/C19H20N4/c1-4-7-17-20-15-11-13(10-12(2)18(15)22-17)19-21-14-8-5-6-9-16(14)23(19)3/h5-6,8-11H,4,7H2,1-3H3,(H,20,22)
InChIKey
ILXRSCZVHSZGCS-UHFFFAOYSA-N
SMILES
C1(C2=CC(C)=C3NC(CCC)=NC3=C2)N(C)C2=CC=CC=C2N=1
LogP
3.49 at 20℃ and pH6
CAS DataBase Reference
152628-02-9(CAS DataBase Reference)
More
Less

Safety Information

HS Code 
2933.99.8290
More
Less

2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole Usage And Synthesis

Chemical Properties

Grey Powder

Uses

An impurity found in Telmisartan (T017000).

Synthesis

25148-68-9

152628-03-0

152628-02-9

General procedure for the synthesis of 1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-dibenzo[d]imidazole from N-methyl-o-phenylenediamine hydrochloride and 2-n-propyl-4-methyl-6-carboxybenzimidazole: Suspension of 4-methyl-2-n-propyl-1H-benzimidazole-6-carboxylic acid (50 g) in poly(phosphoric acid) (300 g) was heated to 70-75 °C and maintained for 30 minutes. Subsequently, N-methylphthalimide dihydrochloride (45 g) was added in batches for 2 hours and the reaction was continued at 70-75°C for 1 hour. Next, the temperature of the reaction mixture was raised to 130-135°C and maintained for 10 hours. Upon completion of the reaction, the mixture was cooled to 70°C and water (600 mL) was slowly added to maintain the temperature at 60-90°C. Cooling was continued to 30 °C and the pH was adjusted to 8.0-8.5 with an aqueous ammonia solution.Subsequently, the reaction mixture was heated to 50-55 °C and held for 1 h. The solids were collected by filtration and the wet filter cake was washed with hot water (200 ml). The wet filter cake was suspended in water (900 mL), heated to 50-55 °C, stirred for 1 h and filtered, then washed with hot water (100 mL), and the wet filter cake was dried at 70-75 °C to constant weight. The dried product was suspended in methanol (260 mL), heated to 45-50 °C, activated carbon (6.5 g) was added and stirred for 30 min. Insoluble material was removed by filtration through a Hyflo bed, the bed was washed with hot methanol (60 mL), the filtrates were combined and cooled to 25 °C. Water (160 mL) was slowly added to the filtrate at 25-35°C, heated to reflux temperature and held for 1 hour. The reaction mixture was cooled to 0-5 °C and maintained for 2 h. The resulting solid was filtered, washed with methanol (60 mL) and the wet filter cake was dried at 70-75 °C to constant weight to give 54 g of 4-methyl-6-(1-methylbenzimidazol-2-yl)-2- n-propyl-1H-benzimidazole (77.4% yield), with a water content of 5.85% as determined by KF.

References

[1] Patent: WO2007/10558, 2007, A1. Location in patent: Page/Page column 5; 10-11
[2] Journal of Medicinal Chemistry, 1993, vol. 36, # 25, p. 4040 - 4051
[3] European Journal of Medicinal Chemistry, 2016, vol. 115, p. 161 - 178

2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazoleSupplier

ShangHai Siyan Biological Technology Co., Ltd. Gold
Tel
021-50908862,442785678,326799392 18721037013
Email
siyansales@126.com
Harway Pharma CO., LTD Gold
Tel
0546-5612566 13793982289
Email
lucy@harwaypharma.com
Shandong Mingfeng Pharmaceutical and Technology Co. Ltd Gold
Tel
-1345456643 15315114555
Email
1345456643@qq.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
INTATRADE GmbH
Tel
+49 3493/605464
Email
sales@intatrade.de